GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Duearity AB (OSTO:DEAR) » Definitions » Return-on-Tangible-Equity

Duearity AB (OSTO:DEAR) Return-on-Tangible-Equity : 0.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Duearity AB Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Duearity AB's annualized net income for the quarter that ended in Dec. 2023 was kr-52.40 Mil. Duearity AB's average shareholder tangible equity for the quarter that ended in Dec. 2023 was kr-3.56 Mil. Therefore, Duearity AB's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was N/A%.

The historical rank and industry rank for Duearity AB's Return-on-Tangible-Equity or its related term are showing as below:

OSTO:DEAR' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -1424.53   Med: -216.6   Max: -34.93
Current: -1113.58

During the past 4 years, Duearity AB's highest Return-on-Tangible-Equity was -34.93%. The lowest was -1,424.53%. And the median was -216.60%.

OSTO:DEAR's Return-on-Tangible-Equity is ranked worse than
98.42% of 760 companies
in the Medical Devices & Instruments industry
Industry Median: 1.395 vs OSTO:DEAR: -1113.58

Duearity AB Return-on-Tangible-Equity Historical Data

The historical data trend for Duearity AB's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duearity AB Return-on-Tangible-Equity Chart

Duearity AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
-34.93 -208.19 -225.00 -1,424.53

Duearity AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -213.75 -186.69 -331.91 -9,496.25 -

Competitive Comparison of Duearity AB's Return-on-Tangible-Equity

For the Medical Devices subindustry, Duearity AB's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Duearity AB's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Duearity AB's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Duearity AB's Return-on-Tangible-Equity falls into.



Duearity AB Return-on-Tangible-Equity Calculation

Duearity AB's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-26.19/( (6.063+-2.386 )/ 2 )
=-26.19/1.8385
=-1,424.53 %

Duearity AB's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-52.4/( (-4.737+-2.386)/ 2 )
=-52.4/-3.5615
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Duearity AB  (OSTO:DEAR) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Duearity AB Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Duearity AB's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Duearity AB (OSTO:DEAR) Business Description

Traded in Other Exchanges
Address
Krusegrand 42D, Malmo, SWE, 212 25
Duearity AB is a medical technology company. It develops smallest and flexible products and services for tinnitus under the Tinearity brand.

Duearity AB (OSTO:DEAR) Headlines